Nerr Pharma Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Nerr Pharma Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Food Manufacturing

Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | General Line Grocery Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Electronic Shopping and Mail-Order Houses | Other Information Services | All Other Information Services | Computer Systems Design and Related Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Full name: Nerr Pharma Sp. z o.o.

Profile Updated: April 12, 2024

Nerr Pharma Sp. z o.o is a pharmaceutical company. The company develops and markets dietary supplements, functional foods, and pharmaceutical products for patients with excess body mass, metabolic disorders, diabetes, high risk of circulatory system disease, and digestive diseases.

Headquarters
Ul. Aleja Fryderyka Chopina 57A
Lomianki Dolne; Mazowieckie; Postal Code: 05-092

Contact Details: Purchase the Nerr Pharma Sp. z o.o. report to view the information.

Website: http://www.axxispharma.com

Basic Information

Total Employees:

Purchase the Nerr Pharma Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Nerr Pharma Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Nerr Pharma Sp. z o.o. report to view the information.

Incorporation Date:

February 08, 2013

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

77.9%

Purchase this report to view the information.

15.7%

Company Performance

Financial values in the chart are available after Nerr Pharma Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

55.54%▲

Total operating revenue

55.54%▲

Operating profit (EBIT)

144.54%▲

EBITDA

133.46%▲

Net Profit (Loss) for the Period

108.36%▲

Total assets

67.34%▲

Total equity

271.31%▲

Operating Profit Margin (ROS)

4.77%▲

Net Profit Margin

2.83%▲

Return on Equity (ROE)

-42.5%▼

Similar companies